Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-067121
Filing Date
2005-03-31
Accepted
2005-03-31 16:32:20
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 UNIGENE LABORATORIES INC d10k.htm 10-K 810795
2 AMENDED BY-LAWS OF THE REGISTRANT dex32.htm EX-3.2 31542
3 FORM OF STOCK OPTION AGREEMENT UNDER 2000 STOCK OPTION PLAN dex1054.htm EX-10.54 28119
4 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 1896
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8412
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8484
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3340
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3360
  Complete submission text file 0001193125-05-067121.txt   898404
Mailing Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193
Business Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193 9738820860
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16005 | Film No.: 05720849
SIC: 2833 Medicinal Chemicals & Botanical Products